Ritter Pharmaceuticals Garners $5,801,545 New Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8f013a90-cd2d-4986-9cb1-7738e088147f&Preview=1 -
Date
8/7/2012 -
Company Name
Ritter Pharmaceuticals -
Mailing Address
1880 Century Park East Los Angeles, CA 90067 -
Company Description
Ritter is committed to the discovery, development and commercialization of novel therapeutic treatments for gastrointestinal diseases and conditions. -
Website
http://www.ritterpharmaceuticals.com -
Transaction Type
Venture Equity -
Transaction Amount
$5,801,545 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
